NASDAQ:BSPM - Biostar Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.52 +0.01 (+1.96 %)
(As of 11/16/2018 02:05 PM ET)
Previous Close$0.51
Today's Range$0.51 - $0.52
52-Week Range$0.51 - $5.97
Volume1,781 shs
Average Volume390,368 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

Receive BSPM News and Ratings via Email

Sign-up to receive the latest news and ratings for BSPM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BSPM
Previous Symbol
CUSIPN/A
Phone011-86-29-3368-6638

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees200
Outstanding Shares2,640,000
Market Cap$0.00
OptionableNot Optionable

Biostar Pharmaceuticals (NASDAQ:BSPM) Frequently Asked Questions

What is Biostar Pharmaceuticals' stock symbol?

Biostar Pharmaceuticals trades on the NASDAQ under the ticker symbol "BSPM."

How were Biostar Pharmaceuticals' earnings last quarter?

Biostar Pharmaceuticals Inc (NASDAQ:BSPM) issued its quarterly earnings results on Wednesday, November, 15th. The company reported ($0.50) EPS for the quarter. During the same period in the previous year, the business earned ($3.12) EPS. View Biostar Pharmaceuticals' Earnings History.

When is Biostar Pharmaceuticals' next earnings date?

Biostar Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, November 19th 2018. View Earnings Estimates for Biostar Pharmaceuticals.

Has Biostar Pharmaceuticals been receiving favorable news coverage?

News stories about BSPM stock have been trending positive on Friday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Biostar Pharmaceuticals earned a daily sentiment score of 2.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the stock's share price in the near future.

Who are some of Biostar Pharmaceuticals' key competitors?

Who are Biostar Pharmaceuticals' key executives?

Biostar Pharmaceuticals' management team includes the folowing people:
  • Mr. Ronghua Wang, Chairman, CEO & Pres (Age 62)
  • Mr. Zhenghong Wang, Chief Operating Officer (Age 38)
  • Ms. Xiaojuan Zhai, Chief Financial Officer (Age 29)
  • Prof. Xiaohui Zheng, Chief Scientist (Age 50)
  • Ms. Shuang Gong, Director of Admin. & Sec. of Board (Age 51)

How do I buy shares of Biostar Pharmaceuticals?

Shares of BSPM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biostar Pharmaceuticals' stock price today?

One share of BSPM stock can currently be purchased for approximately $0.52.

What is Biostar Pharmaceuticals' official website?

The official website for Biostar Pharmaceuticals is http://www.biostarpharmaceuticals.com.

How can I contact Biostar Pharmaceuticals?

Biostar Pharmaceuticals' mailing address is NO. 588 SHIJI XI AVENUE, XIANYANG SHAANXI PROVINCE F4, 712046. The company can be reached via phone at 011-86-29-3368-6638.


MarketBeat Community Rating for Biostar Pharmaceuticals (NASDAQ BSPM)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  151 (Vote Outperform)
Underperform Votes:  140 (Vote Underperform)
Total Votes:  291
MarketBeat's community ratings are surveys of what our community members think about Biostar Pharmaceuticals and other stocks. Vote "Outperform" if you believe BSPM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BSPM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/16/2018 by MarketBeat.com Staff

Featured Article: Float

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel